Thermo Fisher Scientific Inc. (0R0H.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 219.4B |
| Enterprise Value | 250.4B |
| P/E Ratio | 25.47 |
| PEG Ratio | 3.89 |
| Price/Sales Ratio | 3.82 |
| Price/Book Ratio | 3.32 |
| Enterprise/Revenue | 4.7 |
| Enterprise/EBITDA | 19.03 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.15 |
| Operating Margin | 0.18 |
| Return On Assets | 0.06 |
| Return On Equity | 0.13 |
| Revenue | 44.56B |
| Revenue/Share | 121.5 |
| Gross Profit | 16.78B |
| EBITDA | 11.51B |
| Net Income | 6.74B |
| Diluted EPS | 17.74 |
| Total Cash | 3.26B |
| Total Cash/Share | 8.75 |
| Total Debt | 43.16B |
| Total Debt/Equity | 0.83 |
| Current Ratio | 1.53 |
| Book Value Per Share | 139.62 |
| 52-Week Change | 18.99 |
| 52-Week High | 603.14 |
| 52-Week Low | 416.66 |
| Moving Average 50 Days | 556.84 |
| Moving Average 200 Days | 522.32 |
| Average Volume | 13,249 |
| Shares Outstanding | 371.62M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 1.8 |
| Trailing Annual Dividend Yield | 0.39 |
| Payout Ratio | 0.09 |
| Last Split Factor | N/A |
| Last Split Date | N/A |